Welcome to our dedicated page for SenesTech news (Ticker: SNES), a resource for investors and traders seeking the latest updates and insights on SenesTech stock.
SenesTech, Inc. (Nasdaq: SNES) is a pioneering biotechnology company based in the United States, specializing in the development of innovative fertility control solutions for managing animal pest populations. SenesTech is dedicated to improving global health through humane pest control methods, reducing the reliance on traditional lethal techniques.
The company’s flagship product, ContraPest®, is the first and only U.S. EPA-registered contraceptive for male and female rats. As a highly palatable liquid, ContraPest disrupts the reproductive cycle of Norway and roof rats, effectively reducing their populations. The product is dispensed inside tamper-resistant bait stations to minimize risks to non-target species and ensure the safety of handlers. ContraPest can be integrated into existing pest management programs or used as a standalone solution.
SenesTech's latest innovation, Evolve™, an EPA-designated minimum-risk contraceptive for rats, showcases the company's commitment to sustainable and humane pest control solutions. Evolve, available in a soft bait format, was launched in early 2024 and has already seen significant market acceptance. Its rapid adoption by distributors and end customers underscores its effectiveness in managing rodent populations by targeting their reproductive capabilities.
The company has expanded its reach by establishing distribution agreements with international partners, such as Agro Technic in Singapore, Evicom in Australia and New Zealand, and Q-chem in The Netherlands. These partnerships are pivotal in introducing SenesTech's fertility control solutions to new markets and enhancing global pest management strategies.
In addition to its product innovations, SenesTech has been recognized for its commercial achievements. The company was recently accepted as a vendor for Ace Hardware, allowing over 4,500 stores to order directly from SenesTech. Furthermore, SenesTech has launched a dedicated online store on Amazon, providing consumers and professionals with easy access to Evolve.
Financially, SenesTech reported record quarterly revenues in early 2024, driven by the rapid adoption of Evolve. The company's strategic initiatives, including the development of a contraceptive product for mice and operational efficiencies, are expected to sustain this growth trajectory.
SenesTech's mission is clear: to promote clean cities, efficient businesses, and happy households by providing humane, effective, and sustainable pest control solutions. For more information, visit SenesTech and ContraPest Store.
SenesTech, Inc. (NASDAQ: SNES) reported a 138% increase in Q1 2021 revenues to approximately $88,000 year-on-year, with operating expenses reduced by 20%. The company, specializing in rodent fertility control, experienced significant traction in California due to legislation prohibiting certain rodenticides. Cash reserves stand at $15.2 million, supporting future growth. Notable successes included significant population reductions of rats observed in agricultural settings. The firm has transitioned to a solutions-based model and rebranded itself as 'The Pest Control Difference.'
SenesTech, Inc. (NASDAQ: SNES), known for its innovative fertility control solutions for pest management, will release its financial results for the first quarter of 2021 on May 13, 2021, after market close. A conference call to discuss the results is scheduled for the same day at 5:00 pm ET. The company emphasizes its commitment to revolutionizing pest control through its proprietary technology, ContraPest®, which targets reproduction in rat populations. This approach aims to reduce reliance on lethal pest management methods.
SenesTech (NASDAQ: SNES) has launched a new brand campaign, "The Pest Control Difference," highlighting its revolutionary ContraPest® product aimed at managing rodent populations through fertility control. The rebrand signifies the company's transition to a solutions-oriented, environmentally responsible entity within pest management. ContraPest®, proven effective in reducing rat populations non-lethally, is now available for use across all 50 states. Key initiatives include partnerships with distributors and a new loyalty program.
SenesTech, Inc. (NASDAQ: SNES) has renewed and expanded its distribution agreement with Agri-Turf Distributing for ContraPest in California. This partnership aims to enhance the marketing and sales of ContraPest, which effectively controls rat populations through fertility management. With Agri-Turf's expertise in pest management, both companies plan joint marketing initiatives to meet growing demand. ContraPest targets reproductive capabilities in rats, providing a safe, non-lethal pest control solution. The collaboration marks an important step in SenesTech's strategy to revolutionize pest management.
SenesTech, Inc. (NASDAQ: SNES) reported a 97% increase in revenue for 2020, totaling approximately $282,000, compared to $143,000 in 2019. Key deployments of ContraPest demonstrated significant success in reducing rat populations by 90% at an egg production farm and 99% at an urban site. The California Ecosystems Protection Act now prohibits certain rodenticides, offering a potential $100 million market for ContraPest. Despite a net loss of $(8.4) million, improved operational efficiency and successful fundraising efforts position SenesTech well for future growth.
SenesTech, Inc. (NASDAQ: SNES) has partnered with Liphatech, Inc. to develop a non-liquid formulation of ContraPest®, an innovative pest management product aimed at controlling rat populations through fertility control. This collaboration aims to leverage Liphatech's expertise in soft bait technology and SenesTech's proven formula to create a new product offering. ContraPest has successfully reduced rat populations over five years of deployment, currently available in a liquid form approved by the EPA. The development of a new formulation represents a strategic expansion of SenesTech's pest control solutions.
SenesTech, Inc. (NASDAQ: SNES), a leader in fertility control technologies for pest management, announced its participation at the Lytham Partners Spring 2021 Investor Conference on March 31, 2021, at 12:30 PM ET. A webcast of the presentation will be available on the company's website and archived for later access. The event runs from March 30 to April 1, 2021, with virtual one-on-one meetings available by arrangement. SenesTech aims to revolutionize pest control with its product, ContraPest®, which targets reproduction in rat populations, promoting a non-lethal approach.
SenesTech, Inc. (NASDAQ: SNES) has completed a registered direct offering of 1,975,000 shares of common stock priced at $2.00 each, generating gross proceeds of $3.95 million. The funds will be allocated for working capital and general corporate purposes. H.C. Wainwright & Co. served as the exclusive placement agent for this offering. The shares were made available under a previously effective shelf registration statement filed with the SEC.
SenesTech, Inc. (NASDAQ: SNES) announced successful results from a long-term study of its fertility control product, ContraPest®, in an east coast urban area. The study demonstrated a 94% reduction in rat activity at Site A and a 99% reduction at Site B, with juvenile rat populations declining by 98% and 100%, respectively. The city's integrated pest management program plans to expand the deployment of ContraPest® as part of a comprehensive rodent control strategy. CEO Ken Siegel emphasized the potential for similar applications in urban settings across the U.S.
On March 19, 2021, SenesTech (NASDAQ: SNES) announced a registered direct offering of 1,975,000 shares of common stock at $2.00 per share, aiming for gross proceeds of $3.95 million. The offering is set to close around March 23, 2021, subject to customary conditions. Proceeds will be utilized for working capital and corporate purposes. H.C. Wainwright & Co. is the placement agent for this offering, which follows a Form S-3 registration statement effective since August 24, 2018.
FAQ
What is the current stock price of SenesTech (SNES)?
What is the market cap of SenesTech (SNES)?
What is SenesTech, Inc.?
What products does SenesTech offer?
How does ContraPest work?
What are the benefits of using Evolve?
Who are SenesTech’s distribution partners?
Where can I purchase SenesTech products?
What is the financial outlook for SenesTech?
What makes SenesTech's products unique?
Are SenesTech’s products safe for non-target species?
What is SenesTech's mission?
